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Abstract Recent reports have implicated a possible but undefined role for reactive oxygen species in the induction and mediation of apoptosis. In 
the present study, the role of free radicals and metal ions in apoptosis induced in rat thymocytes by dexamethasone and etoposide was examined. 
Copper chelators, but not iron specific chelators, inhibited apoptosis induced by both these stimuli. Several antioxidants also possessed potent 
inhibitory effects. We therefore propose that diverse agents may induce apoptosis in thymocytes by a common mechanism involving a copper mediated 
Fenton reaction, generating site specific hydroxyl radicals, possibly as a result of activation of the redox sensitive transcription factor NF-KB. 
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1. Introduction 
Apoptosis is a form of cell death characterized by cell shrink- 
age, membrane blebbing and DNA fragmentation [ 11. It can be 
induced by a variety of stimuli such as ionizing radiation, glu- 
cocorticoids, chemotherapeutic agents and lymphokine dep- 
rivation [1,2]. Recently there has been an immense amount of 
interest in characterizing mechanisms underlying apoptosis be- 
cause of the potential applications to treating diseases such as 
cancer, autoimmune disease and AIDS [2,3]. Although the sig- 
nals which induce apoptosis in various systems vary markedly, 
the morphological features of apoptosis are conserved in di- 
verse cell types [1,4]. This suggests a possible convergence of 
metabolic events which then results in activation of the cellular 
machinery responsible for apoptosis. Despite the identification 
of genes responsible for both apoptosis and its suppression 
[2,5], the critical biochemical events which result in apoptosis 
remain unclear. 
Oxidative stress has been suggested to play a role as a com- 
mon mediator of apoptosis [6] and recent independent observa- 
tions in diverse systems support a role for oxidative mecha- 
nisms in the induction of apoptosis [7-121. Aerobic organisms 
generate reactive oxygen species during normal metabolism 
and have consequently developed many antioxidant systems for 
purposes of cellular protection [13,14]. The hypothesis that 
such species may be utilized by cells to induce apoptosis is 
supported by the observations that oxidants or treatments 
which generate reactive oxygen species, such as hydrogen 
peroxide [7], t-butyl hydroperoxide [15], radiation [16] and 
tumor necrosis factor [17] induce apoptosis, while the antiox- 
idants N-acetylcysteine [8,11], butylated hydroxyanisole [12], 
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vitamin E analogs [18] and glutathione peroxidase [8] inhibit 
apoptosis to varying extents dependent on the biological sys- 
tem. In addition, the proto-oncogene bcl-2, which inhibits 
many forms of apoptotic cell death, has been suggested to 
mediate an antioxidant pathway to prevent apoptosis [8,9]. 
There has not been a systematic study of the potential role 
of free radicals in apoptosis in a single well-defined system. It 
remains unclear if radicals are critical mediators of apoptosis, 
and if so the species involved, their mechanism and sites of 
generation and the process responsible for activation of the 
apoptotic machinery. In order to address these problems, we 
have examined the effects of metal chelators and inhibitors of 
radical mediated processes on dexamethasone and etoposide 
induced apoptosis in rat thymocytes, a well characterized 
model system for the study of apoptosis [19,20]. We demon- 
strate a key role for copper in the induction of apoptosis in rat 
thymocytes, most probably mediated by free radicals generated 
via a Fenton reaction. 
2. Materials and methods 
2.1. Reagents 
Trolox, 1,7- and 4,7-phenanthroline, N,N’-diphenyl-I ,Cphenylenedi- 
amine (DPDD) and 5,5’-dimethyl-l-pyrroline-N-oxide (DMPO) were 
obtained from Aldrich Chemical Co. Ltd., Dorset, UK. 1,2-Diethyl-3 
hydroxypyridin4-one (CP-94) was a gift from Dr. R.C. Hider, Kings 
College, London, UK. Unless otherwise stated all other chemicals were 
purchased from Sigma Chemical Co., Dorset, UK. 
2.2. Preparation and treatment of rat thymocytes 
Male Fischer 344 rats (65-85 g), bred at the University of Leicester 
and allowed food and water ad libitum, were sacrificed with an over- 
dose of Sagatal (pentobarbitone, 60 mg/kg i.p.) (May & Baker Ltd, 
Dublin, Ireland). Thymocytes were isolated as previously described [21] 
and diluted to a final density of 20 x IO6 cells/ml with RPM1 1640 
(Gibco, Paisley, UK) gassed with 95% 0,/5% CO, and supplemented 
with 10% fetal bovine serum (Gibco). Isolated thymocytes were incu- 
bated for 4 h either alone (as controls), with etoposide (10 PM) or 
dexamethasone (0.1 PM) at 37°C in a humidified 95% sir/5% CO1 
atmosphere in a final volume of 0.5 ml in 24-well plates. 
Antioxidants/chelators, where used, were added in nontoxic concen- 
trations (as assessed by propidium iodide exclusion), 10 min prior to 
the addition of dexamethasone or etoposide unless stated. N-Acetylcys- 
teine was dissolved in PBS and neutralized before addition. Other 
compounds were dissolved in either ultrapure (18 MR) water (EDTA, 
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EGTA, Detapac, desferrioxamine, CP-94, PDTC, Tempol, DMPO and 
ascorbate) thanol (neocuproine, l,lO-phenanthroline-and its analogs, 
BHA. vitamin E succinate and PBN) or DMSO (Trolox and DPPD). 
The volume of vehicle added was normally 1% v/G but was reduced tb 
0.5% v/v in the case of DMSO. Controls using vehicle alone were 
performed in each experiment. All chelators were weighed out using 
non-metal spatulas. 
2.3. Quantitation of apoptosis by flow cytometry 
Subsequent to treatment, thymocytes were incubated with Hoechst 
33342 and propidium iodide to quantify the percentage of apoptotic 
cells, essentially as previously described [22], except that analysis was 
performed using the Becton Dickinson FACS Vantage flow cytometer. 
The cells with high blue fluorescence due to increased Hoechst 33342 
intensity have previously been shown to be apoptotic based on a num- 
ber of criteria including decreased size, ultrastructure and the presence 
of DNA ladders [22,23]. 
2.4. Agarose gel electrophoresis 
After incubation at 37”C, 2 x IO6 cells/lane were analysed for the 
presence of oligonucleosomal fragmentation on 1.8% agarose gels as 
described [24]. 
2.5. Statistical analysis 
Data were taken from experiments performed on separate days using 
different animals. Data were analyzed either by a one way analysis of 
variance followed by a post-hoc Dunnett’s t-test for comparison of 
multiple groups to a single control or in some cases by a paired Stu- 
dent’s t-test. The significance level was set at P 5 0.05. 
3. Results 
3.1. Effects of iron and copper chelators on apoptosis 
Apoptosis was induced in rat thymocytes by both the gluco- 
corticoid, dexamethasone [1,2,4] and the DNA topoisomerase 
II inhibitor, etoposide (VP-16) [25] and the ability of both metal 
chelators and antioxidants to modulate apoptosis by these 
agents was examined. The thiocarbamate PDTC, which has 
both metal chelating and antioxidant properties [26], caused a
concentration dependent inhibition of both dexamethasone 
and etoposide induced apoptosis (Fig. 1A). In order to examine 
the role of metals in more detail, the effects of other chelators 
were then examined. l,lO-Phenanthroline, which is used to 
chelate both iron and copper [27], also effectively inhibited 
apoptosis induced by both etoposide and dexamethasone (Fig. 
1 B). In contrast, the non-chelating analogs of phenanthroline, 
1,7_phenanthroline (100 PM) and 4,7_phenanthroline (100 PM) 
[28] had relatively little or no effect on either dexamethasone 
or etoposide induced apoptosis (Table I), suggesting that the 
effects observed were due to the metal chelating properties of 
the phenanthroline molecule. These results suggested the in- 
volvement of either iron or copper in the induction of apoptosis 
in thymocytes. 
The membrane permeable iron III chelators, CP-94 [29] and 
desferrioxamine [29] had no effect on apoptosis (Fig. 1C and 
D). Similar results were obtained when the preincubation 
period of desferrioxamine with cells was extended from 10 min 
to 2 h prior to dexamethasone or etoposide addition. Similarly 
ferrozine, a compound used to chelate iron II ions [30], had 
little effect on etoposide or dexamethasone induced apoptosis 
(Table 1). In marked contrast to the iron chelators, neocupro- 
ine, a phenanthroline with a high affinity for copper ions 
[28,31], was a potent inhibitor of both etoposide and dexam- 
ethasone induced apoptosis (Fig. 1E). The effects of EDTA, 
EGTA and Detapac were also examined in this system but these 
compounds had little effect on apoptosis induced by either 
stimuli (Table l), probably due to their limited membrane per- 
meability under physiological conditions [29]. The effects of 
1 , 1 0-phenanthroline and neocuproine suggest an important 
role for copper but not iron in the induction of apoptosis in 
thymocytes. 
3.2. Inhibition of apoptosis by radical scavengers 
The ability of traces of soluble iron or copper to form highly 
reactive hydroxyl radicals (‘OH) by a metal catalyzed Fenton 
reaction is well known [32,33]. We therefore examined the ef- 
fects of the nitroxide spin probe, Tempol, and the spin trap 
PBN, which are both membrane-permeable free radical scaven- 
gers [34-361. Tempo1 effectively inhibited both etoposide and 
dexamethasone induced apoptosis to control levels (Fig. 1F) 
supporting a role for free radicals in apoptosis. Pretreatment 
of cells with PBN also markedly inhibited apoptosis (Fig. 1G). 
The involvement of free radicals was also supported by the 
modest inhibition of both etoposide and dexamethasone in- 
duced apoptosis by the antioxidant BHA and the spin trap 
DMPO. DMPO (50 mM) inhibited both dexamethasone 
(32.9 + 2.0% to 24.3 f 2.2%, n = 4, P 5 0.05) and etoposide 
(46.7 f 4.5% to 41.6 + 4.1%, n = 4, P I 0.05) induced apopto- 
sis. BHA (O.lmM) also inhibited dexamethasone (33.8 f 2.9% 
to 25.9 f 3.5%, n = 5, P I 0.05) and etoposide (49.7 + 4.5% to 
43.2 + 3.4%, n = 4, P I 0.05) induced apoptosis. Several other 
antioxidants, including ascorbate and Trolox, did not markedly 
inhibit apoptosis induced by either stimuli (Table 1). These 
results indicated that the antioxidants and chelators used in 
Table 1 exhibited little or no inhibitory effects on apoptosis 
compared to those obtained with PDTC, l,lO-phenanthroline, 
neocuprine, Tempo1 or PBN (Fig. 1). 
Table 1 
Effects of antioxidants and chelators on apoptosis 
Addition” Concentration Inhibition” 















50 ;IM 6.2 5.3 
IOOPM 2.3 2.8 
100 pM +0.4 
10 mM 1.4 
30 mM 3.8 
100 /LM +0.1 
1 mM 3.7 
1mM 4.6 
1mM 0.2 
100 ,uM 1.8 












A concentration range of each compound was examined in order to 
establish a non-toxic concentration. The results represent either single 
values or means of two determinations. 
Thymocytes were incubated for 10 min at 37°C prior to a further 
incubation of 4 h in the presence of either dexamethasone (0.1 ,uM) or 
etoposide (10 @M). Apoptosis was then assessed by flow cytometry. 
Values shown represent he decrease in the total percentage of cells 
undergoing apoptosis induced by either dexamethasone or etoposide. 
Values preceeded by a plus sign showed an increase in apoptosis. 
% apoptosis induced by dexamethasone and etoposide were 34.2 +_ 2.2 
and 49.7 f 6.6 (Means f S.E., n = 8) respectively. 
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3.3. Copper but not iron chelators inhibit internucleosomal 
cleavage of DNA 
Cleavage of DNA into nucleosomal fragments of 180-200 
base pairs or multiples thereof has often been considered as the 
biochemical hallmark of apoptosis [37]. Although more recent 
studies have suggested that DNA is initially cleaved into large 
fragments of 20&300 and 3@50 kilobase pairs in length [25,38], 
possibly representing rosettes and loops in higher order chro- 
matin structure [39], the recognition of nucleosomal adders is 
still a useful marker of apoptosis, particularly in thymocytes. 
A small amount of intemucleosomal cleavage was observed in 
control cells (Fig. 2A and B, lane 1) consistent with a small 
amount of control apoptosis (Fig. 1). Following incubation for 
4 h with dexamethasone (Fig. 2A, lane 2) or etoposide (Fig. 2B, 
lane 2) a marked increase in internucleosomal cleavage was 
observed in agreement with many previous studies [25,37]. Co- 
incubation of thymocytes in the presence of dexamethasone or 
etoposide in the presence of the copper chelators, neocuproine, 
1, lo-phenanthroline and PDTC, prevented this increase (Figs. 
2A and B, lanes 3-5, respectively) consistent with the observed 
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Fig. 1. Effects of free radical scavengers and metal chelators on dexam- 
ethasone and etoposide induced apoptosis. Thymocytes were incubated 
for 4 h with either dexamethasone (0.1 PM) (m) or etoposide (10 PM) 
(A) and then apoptosis assessed by flow cytometry. Thymocytes were 
incubated in the presence of the indicated concentrations of various 
compounds and the results represent the mean C3.E.M. of at least three 
determinations. The shaded area represents the control level of apopto- 
sis without any added inducing agent. motes significantly different to 
the value obtained with either dexamethasone or etoposide alone, 
P < 0.05. 
inhibition of apoptosis as assessed by flow cytometry (Fig. 1). 
Similarly, Tempol, the free radical scavenger, markedly inhib- 
ited dexamethasone (Fig. 2A, lane 6) and etoposide (Fig. 2B, 
lane 6) induced internucleosomal cleavage in agreement with its 
ability to inhibit apoptosis (Fig. 1). In contrast, the iron chela- 
tors, CP-94 and desferrioxamine, did not inhibit dexam- 
ethasone or etoposide induced increases in internucleosomal 
cleavage (Figs. 2A and B, lanes 7 and 8, respectively) consistent 
with their inability to inhibit apoptosis as assessed by flow 
cytometry (Fig. 1). BHA appeared to cause a slight decrease in 
DNA laddering while N-acetylcysteine had little effect (Fig. 2A 
and B, lanes 10 and 9 respectively). Thus compounds which 
inhibited apoptosis also inhibited internucleosomal cleavage of 
DNA, while those compounds which had little effect on apop- 
tosis similarly did not inhibit internucleosomal DNA fragmen- 
tation. 
4. Discussion 
Our data provide strong evidence for the involvement of 
metals and free radicals in the induction of apoptosis in rat 
thymocytes following treatment with two agents, dexam- 
ethasone and etoposide, with different mechanisms of action. 
The observations that both metal chelators and radical scaven- 
gers inhibited dexamethasone and etoposide induced apoptosis, 
suggested that hydroxyl radicals, generated via an iron or cop- 
per-mediated Fenton reaction, may play a role in the induction 
of apoptosis. It has previously been shown that l,lO-phenan- 
throline and the hydroxyl radical scavenger, DMSO, inhibited 
apoptosis in porcine aortic endothelial cells via a mechanism 
presumed to involve blocking of iron-mediated Fenton chemis- 
try [lOI. 
4.1. Copper but not iron is involved in the induction of apoptosis 
One of the most interesting aspects of our data was the lack 
of effect of either the ferric ion chelators, CP-94 and desferri- 
oxamine [29], or the ferrous ion chelator, ferrozine [30], to- 
gether with the observation that both 1, lo-phenanthroline and 
neocuproine were potent inhibitors of both dexamethasone and 
etoposide induced apoptosis (Figs. 1 and 2). l,lO-Phenanthro- 
line inhibits both copper and iron-mediated Fenton reactions 
but neocuproine only blocks the copper-mediated reaction [27]. 
Thus our data supports a critical role for copper ions in dexam- 
ethasone and etoposide induced apoptosis. However, we can- 
not totally exclude the possibility of the involvement of other 
metals, as metal chelators are not totally specific for a single 
metal, although the binding constants for different metals vary 
considerably. l,lO-Phenanthroline and even neocuproine, 
which is used as an analytical reagent for the detection of 
copper [40], will also bind zinc, but with a binding constant 
three to four orders of magnitude lower than copper [28,31]. 
Paradoxically, chelation of intracellular zinc has been reported 
to induce apoptosis in rat thymocytes [41]. Thus data obtained 
in this study together with the relative specificity of neocupro- 
ine for copper strongly supports the suggestion that this is the 
metal involved in activation of apoptosis in thymocytes. 
4.2. Involvement offiee radicals in dexamethasone and etoposide 
induced apoptosis 
A marked inhibition of both dexamethasone and etoposide 
induced apoptosis was obtained using the spin probe Tempo1 
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Fig. 2. Inhibition of intemucleosomal c eavage by copper but not iron 
chelators. Thymocytes were incubated for 4 h, (A) with dexamethasone 
(0.1 PM), or (B) with etoposide (IOpM) in the presence or absence of 
various compounds. Thymocytes were incubated either alone (lane 1) 
or with dexamethasone or etoposide either alone (lane 2) or in the 
presence of neocuproine (10 PM) (lane 3), l,lO-phenanthroline (100 
iM) (lane 4), PDTC (10pM) (lane S), Tempo1 (lO>M) (lane 6), CP-94 
(500 uM) (lane 7). desferrioxamine (500 uM) (lane 81, N-acetvlcvsteine 
(30 mM)‘(iane 9)‘and BHA (1OOpM) (lane Id): The cells wereexamined 
for DNA laddering by agarose gel electrophoresis. The distance mi- 
grated by the 564 base pair standard is marked. 
and the spin trap PBN, supporting a role for free radicals in 
apoptosis. This role was also supported by the modest inhib- 
itory effects of the spin trap DMPO and the antioxidant BHA. 
The concentrations of Tempo1 used were similar to those used 
to protect against X-ray induced cytotoxicity and hydrogen 
peroxide-mediated mutagenicity [42,43], whilst those of PBN 
and DMPO were similar to those used in ESR spin trapping 
experiments [44,45]. The spin traps and probes used are nonspe- 
cific free radical scavengers and are not specific for oxygen 
radicals [34,44,46,47]. It is feasible therefore that radicals other 
than the hydroxyl radical may be involved in the induction of 
apoptosis. The greater efficacy of PBN and Tempo1 compared 
to DMPO to inhibit apoptosis may be a result of their increased 
cellular penetration due to increased lipophilicity. The octanol/ 
water partition coefficients for DMPO, PBN and Tempo1 are 
0.03, 11.4 and 5.3, respectively [34-361. Nitroxides, such as 
Tempol, also demonstrate superoxide dismutase like activity 
and under certain conditions can oxidize ferrous ions com- 
plexed to DNA, thereby preventing metal mediated reduction 
of hydrogen peroxide to hydroxyl radicals at a critical site [48]. 
Tempo1 also oxidizes ferrous ions chelated to ADP and blocks 
iron-ADP dependent lipid peroxidation [35]. The effects of 
Tempo1 observed in our study may therefore reflect more than 
one mechanism of action, although the interaction of nitroxides 
with complexed ferrous ions is markedly slower (k = 40 
M-’ . s-l) [48] than with radicals (k = lo’-10 
M-i’s_‘) [34,46]. The antioxidant BHA and the spin 
trap DMPO caused only a modest inhibition of apoptosis 
whilst several other antioxidants had little or no inhibitory 
effects (Table 1). Their lack of inhibition may be due to an 
inability to achieve adequate concentrations at the sites of free 
radical generation. Alternatively, since some compounds such 
as N-acetylcysteine have been shown to effectively inhibit apop- 
tosis in other systems [8,11], their inactivity in our study may 
reflect a varying susceptibility of different apoptotic systems to 
inhibition. Previous independent observations have docu- 
mented the ability of free radical scavengers to inhibit apoptosis 
to varying degrees in diverse systems [8,11,12,18]. These data 
are consistent with our results and therefore suggest hat a role 
for free radicals in apoptosis may not be limited to thymocytes. 
4.3. Potential mechanisms of apoptosis 
It is possible that the inhibitory metal chelators and antioxi- 
dants used in our study exert their effects independently. 
Whether the requirement for metals reflects the involvement of 
specific metalloenzymes or metal-dependent transcription fac- 
tors requires further investigation. Our findings that both metal 
chelators and radical scavengers inhibited dexamethasone and 
etoposide induced apoptosis, however, suggested the involve- 
ment of a copper mediated Fenton reaction. Copper is an 
efficient mediator of this reaction, generating highly reactive 
hydroxyl radicals, which can cause oxidative damage to pro- 
teins, lipids and site specific damage in DNA [27,32,49-521. A 
copper mediated Fenton reaction also requires the presence of 
hydrogen peroxide and it is not known whether addition of 
etoposide or dexamethasone tothymocytes timulates peroxide 
production. 
A major objection to a role for oxygen radicals in apoptosis 
concerns the mechanism whereby the specificity of the apop- 
totic process could be maintained with such indiscriminate re- 
actants. Although not all radicals are reactive, many, such as 
‘OH, react rapidly with biological macromolecules. Metals 
such as copper II are relatively insoluble and remain in solution 
only by chelation with cellular components [32,33]. As the metal 
is localized at a specific site, any highly reactive free radicals 
formed will attack close to their site of generation resulting in 
localized damage [32,33]. This mechanism would explain how 
reactive radicals may react in a controlled manner to activate 
cellular machinery leading to apoptosis. One such attractive 
possibility is a metal and radical dependent ranscriptional ac- 
tivation leading to apoptosis. It is interesting that 1, lo-phenan- 
throline blocks the binding of an activated glucocorticoid-re- 
ceptor complex to DNA [53] and these authors suggested that 
the activated complex was a metalloprotein. Oxidative stress is 
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known to activate the transcription factor NF-KB and antioxi- 
dants can inhibit this process [54,55]. Dithiocarbamates are 
known inhibitors of NF-KB activation and the most potent 
inhibitor identified in a recent study was PDTC [26], which in 
our hands markedly inhibited both dexamethasone and eto- 
poside induced apoptosis. These data suggest hat NF-KB may 
be a critical modulator of apoptosis and Sikora et al. [56] have 
recently shown that in thymocytes both AP-1 and NF-KB are 
activated during apoptosis induced by heat shock and dexam- 
ethasone. Activation of NF-KB as a mechanism underlying 
apoptosis in thymocytes and the role of copper and free radicals 
in this process are currently under investigation. 
In summary, our data demonstrate a critical role for metals, 
specifically copper, and free radicals in the induction of apopto- 
sis from diverse stimuli in rat thymocytes.We suggest that cop- 
per-mediated Fenton reactions generate site specific free radi- 
cals, such as hydroxyl radicals, leading to apoptosis possibly as 
a result of activation of the transcription factor, NF-ICB. 
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